TIM3 Antibody from FORTIS LIFE SCIENCES
Search, find, compare suppliers for anti-TIM3 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | TIM3 |
| Clone | monoclonal |
| Host Species | Recombinant Rabbit |
| Reactive Species | mouse |
| Isotype | n/a |
| Format | purified |
| Size | 20 µl (2 blots) |
| Concentration | 100 µg/ml |
| Applications | WB, IP |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Rabbit anti-TIM3 Recombinant Monoclonal Antibody [BLR207K]. TIM3 (HAVCR2) is a cell surface receptor implicated in modulating innate and adaptive immune responses. It is generally accepted to have an inhibiting function. Reports on stimulating functions suggest that the activity may be influenced by the cellular context and/or the respective ligand. TIM3 regulates macrophage activation, inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and alloimmune responses, and promotes immunological tolerance. In CD8+ cells TIM3 attenuates TCR-induced signaling, specifically by blocking NF-kappaB and NFAT promoter activities resulting in the loss of IL-2 secretion. [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/Q8TDQ0]. |
| Immunogen | Epitope: between 231 and 281 (C-term) |
| Other Names | hepatitis A virus cellular receptor 2 homolog; TIMD-3; Timd3; TIM-3; Tim3; T-cell membrane protein 3; T-cell immunoglobulin mucin receptor 3; T-cell immunoglobulin and mucin domain containing 3; HAVcr-2; CD antigen CD366; T-cell immunoglobulin and mucin domain-containing protein 3 |
| Gene, Accession # | Gene ID: 171285, Accession: NP_599011.2, UniProt: Q8VIM0 |
| Catalog # | A700-207-T |
| Price | $127 |
| Order / More Info | TIM3 Antibody from FORTIS LIFE SCIENCES |
| Product Specific References | n/a |
FORTIS LIFE SCIENCES
FORTIS LIFE SCIENCES
1440 Main Street, Suite 300
Waltham MA 02451
P: 800.338.9579
info@fortislife.com
https://www.fortislife.com
Profile of FORTIS LIFE SCIENCES
Return to Antibodies